Atrasentan Impurity 2 | CAS 195529-62-5 - Request Quote
Atrasentan Impurity 2
| SZ CAT No: | SZ-A221007 |
| CAS No | 195529-62-5 |
| Mol.F. | C19H19NO5 |
| Mol.Wt. | 341.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Atrasentan Impurity 2 is chemically (2R,3R,4S)-4-(benzo[d][1,3]dioxol-5-yl)-2-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid. Atrasentan Impurity 2 is supplied with detailed characterization data compliant with regulatory guideline. Atrasentan Impurity 2 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Atrasentan.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 195529-62-5
Purchase 195529-62-5
Order 195529-62-5
Enquire 195529-62-5
price of 195529-62-5
195529-62-5 Supplier
195529-62-5 Manufacturer
195529-62-5 Exporter
buy high quality Atrasentan Impurity 2
Purchase Atrasentan Impurity 2
Atrasentan Impurity 2 suppliers
Atrasentan Impurity 2 manufacturers
Atrasentan Impurity 2 price
Order Atrasentan Impurity 2
Enquire Atrasentan Impurity 2
Atrasentan Impurity 2 cost
Atrasentan Impurity 2 Supplier
Atrasentan Impurity 2 Distributor
Atrasentan Impurity 2 for Method Validation
Atrasentan Reference Standard
Atrasentan Impurity 2 for ANDA Filing
Atrasentan Impurity 2 for Forced Degradation Studies
Atrasentan Impurity 2 Identification Standards
Atrasentan Impurity 2 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.